Keywords: entremed, shares, rise, hopes, new, partner, endostatin

EntreMed shares rise on hopes of new partner for Endostatin

Article | 16 December 1999

Print This

EntreMed saw its shares rise by a third to $31.69 on recent speculationthat it may sign a new development partner for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in